ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,820,823 | -10.7% | 103,936 | +1.1% | 0.02% | -7.7% |
| Q2 2023 | $3,160,133 | -14.5% | 102,802 | +0.2% | 0.03% | -21.2% |
| Q1 2023 | $3,696,426 | -5.5% | 102,593 | +3.6% | 0.03% | -13.2% |
| Q4 2022 | $3,912,006 | +1.8% | 98,988 | +3.5% | 0.04% | -5.0% |
| Q3 2022 | $3,842,000 | -5.5% | 95,619 | -1.1% | 0.04% | +2.6% |
| Q2 2022 | $4,064,000 | +9.1% | 96,670 | +1.1% | 0.04% | +30.0% |
| Q1 2022 | $3,726,000 | +0.5% | 95,646 | +2.8% | 0.03% | +7.1% |
| Q4 2021 | $3,706,000 | +106.7% | 93,007 | +87.5% | 0.03% | +86.7% |
| Q3 2021 | $1,793,000 | -11.4% | 49,613 | +0.5% | 0.02% | -6.2% |
| Q2 2021 | $2,024,000 | -7.9% | 49,367 | -2.0% | 0.02% | -15.8% |
| Q1 2021 | $2,197,000 | +34.6% | 50,359 | +54.4% | 0.02% | +26.7% |
| Q4 2020 | $1,632,000 | – | 32,613 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |